Green tea extract can effectively treat leukemia

A study by Mayo Clinic in Minnesota shows that EGCG, an active ingredient in green tea, can effectively control the condition of chronic lymphocytic leukemia (CLL), which brings new hope to overcome the disease The results were published in the recent online edition of the Journal of clinical oncology In the clinical trial, researchers at the Mayo Clinic gave 33 patients with chronic lymphocytic leukemia 8 different doses twice a day, ranging from 400 mg to 2000 mg The main active ingredient of the drug is EGCG, and it was found that the number of lymphocytes in patients decreased by one third In addition, the researchers also found that patients had a strong tolerance to the drug, even up to 2000 mg at a time, but still did not reach the maximum tolerable dose of patients The researchers found that patients could not only tolerate the high-dose green tea extract, but also improve their chronic lymphocytic leukemia In patients with enlarged lymph nodes, most of the people who took the drug, their lymph nodes would shrink by half or more At present, this study has entered the second stage, and the number of patients participating in the follow-up clinical trial is approximately the same as that in the first stage Everyone will take the same maximum dose as in the original trial The researchers hope that EGCG can stabilize the condition of patients with early chronic lymphocytic leukemia, or combine with other treatments to improve the treatment effect of the disease.